MedPath

Akucoline

Brand Name: Akucoline

Generic Name: Citicoline (as sodium)

Active
Registration Number

DRP-4974

Dosage Form

Solution for Injection (IM/IV)

Issuance Date

December 3, 2023

Expiry Date

June 17, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength250 mg/mL (500 mg/2 mL) Solution for Injection (IM/IV); 250 mg/mL (1000 mg/4 mL) Solution for Injection (IM/IV)
Packaging2 mL in USP Type I Clear Glass Ampoule (Box of 5's); 4 mL in USP Type I Clear Glass Ampoule with White Ring (Box of 5's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Nootropic
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Citicoline (as sodium)Active
Monograph: Citicoline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform